Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11496
Title: | Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer. | Austin Authors: | John, Thomas ;Yanagawa, Naoki;Kohler, Derek;Craddock, Kenneth J;Bandarchi-Chamkhaleh, Bizhan;Pintilie, Melania;Sykes, Jenna;To, Christine;Li, Ming;Panchal, Devang;Chen, Weisan;Shepherd, Frances A;Tsao, Ming-Sound | Affiliation: | Ludwig Institute for Cancer Research, Austin Health, Melbourne, Australia tom.john@ludwig.edu.au |
Issue Date: | 1-Jul-2012 | Publication information: | Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer; 7(7): 1101-8 | Abstract: | Xenograft models of epithelial malignancies potentially have greater correlation with clinical end points. We implanted 153 primary non-small cell lung carcinomas into non-obese diabetic-severe combined immunodeficient mice to develop primary lung cancer xenografts. Sixty-three xenografts formed. However, in 19 implantations, tumors consisted of a lymphocyte proliferation without a carcinoma component. We further characterized these lymphomas to determine clinicopathological features associated with their formation.Lymphomas were investigated morphologically and by silver in situ hybridization to determine their species of origin. Characterization both of the xenograft lymphomas and the primary NSCLCs from which they were derived included immunohistochemistry for lymphoma markers and Epstein Barr virus Early RNA (EBER) by in situ hybridization. DNA was profiled using the MassARRAY platform; EML4-ALK translocations and lymphocyte infiltration were assessed in the primary tumor. Lymphoma formation was correlated with patient and primary tumor characteristics and survival.The lymphocytic tumors were EBER positive, human diffuse large B-cell lymphomas (DLBCLs). Significantly more DLBCLs that formed in mice arose in primary lung adenocarcinomas and in epithelial growth factor receptor mutant never smokers. DLBCL formation was not associated with the degree of tumor-infiltrating lymphocytes or EBER-positive lymphocytes in the primary NSCLCs. Patients whose tumors developed DLBCL had longer disease-free survival compared with patients whose tumors formed epithelial xenografts (hazard ratio: 0.44; 95% confidence interval: 0.18 -1.06, Wald p = 0.07), regardless of genotype.We hypothesize that mechanisms involved in the active suppression of viral antigens may also be involved in the suppression of tumor antigens, and may have resulted in the observed favorable clinical outcome. | Gov't Doc #: | 22617243 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/11496 | DOI: | 10.1097/JTO.0b013e3182519d4d | Journal: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | URL: | https://pubmed.ncbi.nlm.nih.gov/22617243 | Type: | Journal Article | Subjects: | Adenocarcinoma.complications.mortality.virology Adult Aged Aged, 80 and over Animals Antigens, Viral.immunology.metabolism Carcinoma, Non-Small-Cell Lung.complications.mortality.virology Carcinoma, Squamous Cell.complications.mortality.virology Epstein-Barr Virus Infections.complications Female Gene Rearrangement Herpesvirus 4, Human.genetics.pathogenicity Humans Immunoenzyme Techniques Immunophenotyping In Situ Hybridization Lung Neoplasms.complications.mortality.virology Lymphocytes, Tumor-Infiltrating.immunology.pathology Lymphoma, Large B-Cell, Diffuse.etiology.mortality Male Mice Mice, SCID Middle Aged Mutation.genetics Neoplasm Staging Oncogene Proteins, Fusion.genetics Polymerase Chain Reaction Prognosis RNA, Viral.genetics Survival Rate Transplantation, Heterologous Tumor Markers, Biological.metabolism |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.